Literature DB >> 16793309

Hantavirus cardiopulmonary syndrome: immune response and pathogenesis.

Alessandra A Borges1, Gelse M Campos, Marcos L Moreli, Ricardo L M Souza, Victor H Aquino, Fabiano P Saggioro, Luiz T M Figueiredo.   

Abstract

Hantaviruses are emerging viruses in the Americas that cause cardiopulmonary syndrome with high lethality. The intense cellular immune response to hantavirus alters normal endothelial cell barrier functions and seems to be harmful to the host. On the other hand, the humoral immune response seems to be essential for recovery from infection.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16793309     DOI： 10.1016/j.micinf.2006.04.019

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  26 in total

Review 1.  The Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  David Safronetz; Hideki Ebihara; Heinz Feldmann; Jay W Hooper
Journal:  Antiviral Res       Date:  2012-06-15       Impact factor: 5.970

2.  Truncated hantavirus nucleocapsid proteins for serotyping Sin Nombre, Andes, and Laguna Negra hantavirus infections in humans and rodents.

Authors:  Takaaki Koma; Kumiko Yoshimatsu; Noemi Pini; David Safronetz; Midori Taruishi; Silvana Levis; Rika Endo; Kenta Shimizu; Shumpei P Yasuda; Hideki Ebihara; Heinz Feldmann; Delia Enria; Jiro Arikawa
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

3.  Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus.

Authors:  Kevin B Walsh; John R Teijaro; Peter R Wilker; Anna Jatzek; Daniel M Fremgen; Subash C Das; Tokiko Watanabe; Masato Hatta; Kyoko Shinya; Marulasiddappa Suresh; Yoshihiro Kawaoka; Hugh Rosen; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-29       Impact factor: 11.205

4.  Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection.

Authors:  John R Teijaro; Kevin B Walsh; Stephanie Rice; Hugh Rosen; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-26       Impact factor: 11.205

5.  Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin.

Authors:  Punya Shrivastava-Ranjan; Pierre E Rollin; Christina F Spiropoulou
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

Review 6.  A global perspective on hantavirus ecology, epidemiology, and disease.

Authors:  Colleen B Jonsson; Luiz Tadeu Moraes Figueiredo; Olli Vapalahti
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

7.  Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques.

Authors:  David Safronetz; Joseph Prescott; Friederike Feldmann; Elaine Haddock; Rebecca Rosenke; Atsushi Okumura; Douglas Brining; Eric Dahlstrom; Stephen F Porcella; Hideki Ebihara; Dana P Scott; Brian Hjelle; Heinz Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  Differential pathogenesis between Andes virus strains CHI-7913 and Chile-9717869in Syrian Hamsters.

Authors:  Bryce M Warner; Angela Sloan; Yvon Deschambault; Sebastian Dowhanik; Kevin Tierney; Jonathan Audet; Guodong Liu; Derek R Stein; Oliver Lung; Cody Buchanan; Patrycja Sroga; Bryan D Griffin; Vinayakumar Siragam; Kathy L Frost; Stephanie Booth; Logan Banadyga; Greg Saturday; Dana Scott; Darwyn Kobasa; David Safronetz
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

9.  Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers?

Authors:  Masanori Terajima; Daisuke Hayasaka; Ken Maeda; Francis A Ennis
Journal:  Immunol Lett       Date:  2007-09-12       Impact factor: 3.685

10.  Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects.

Authors:  Ping Liu; Marcia Woda; Francis A Ennis; Daniel H Libraty
Journal:  J Infect Dis       Date:  2009-07-15       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.